Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness-Reference-Cited by-同舟云学术

Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness

Published:2009-05 Issue:7 Volume:45 Page:1218-1231
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Larsen Inger Kristin,Småstuen Milada,Johannesen Tom Børge,Langmark Frøydis,Parkin Donald Maxwell,Bray Freddie,Møller Bjørn

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference36 articles.

1. Det Kongelige Helsedepartement. Forskrift om innsamling og behandling av helseopplysninger i Kreftregisteret (Kreftregisterforskriften) av 21. desember 2001 nr 1477.

2. Pilot study for the evaluation of completeness of reporting to the cancer registry;Lund,1981

3. Quality of prostate cancer data in the cancer registry of Norway;Harvei;Eur J Cancer,1996

4. Head and neck cancer in Norway. A study of the quality of the Cancer Registry of Norway’s data on head and neck cancer for the period 1953–1991;Mork;APMIS,1995

5. Completeness and accuracy of registration of ovarian cancer in the cancer registry of Norway;Tingulstad;Int J Cancer,2002

Cited by 643 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hospital use and cancer treatment by age and socioeconomic status in the last year of life: A Norwegian population-based study of patients dying of cancer;Journal of Geriatric Oncology;2024-03

2. Long-term follow-up of complex oncoplastic breast-conserving surgery, standard breast conservation and skin-sparing mastectomy in DCIS - a register-based study;European Journal of Surgical Oncology;2024-02

3. Prediction of clinically significant recurrence after partial nephrectomy. Data from the Cancer Registry of Norway with more than five years of follow-up;Scandinavian Journal of Urology;2024-01-16

4. Methodological approaches to assessing incidence, survival, and mortality rates in breast cancer in the Russian Federation;Onkologiya. Zhurnal imeni P.A.Gertsena;2024

5. EGFR-mutation testing, treatment patterns and clinical outcomes in patients with stage IB–IIIA non-small cell lung cancer in Norway–a nationwide cohort study;Cancer Treatment and Research Communications;2024